Peer Review reports

From: The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry

Original Submission
17 Mar 2015	Submitted	Original manuscript
	Author responded	Author comments
	Reviewed	Reviewer Report
	Reviewed	Reviewer Report
Resubmission - Version 2
	Submitted	Manuscript version 2
	Author responded	Author comments
	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
3 Dec 2015	Editorially accepted
19 Dec 2015	Article published	10.1186/s13063-015-1100-8

You can find further information about peer review here.

Back to article page